(Reuters) - The company, whose shares rose more than 2 percent, said profit for the first quarter that ended on May 5 declined to $13.65 million, or 21 cents per share, from $15.42 million, or 23 cents per share, a year earlier.
Excluding a gain from the sale of pharmacy-related assets, earnings were 20 cents a share, meeting the analysts' average forecast compiled by Reuters Estimates.
Read more at Reuters.com Business News
Excluding a gain from the sale of pharmacy-related assets, earnings were 20 cents a share, meeting the analysts' average forecast compiled by Reuters Estimates.
Read more at Reuters.com Business News
No comments:
Post a Comment